Matches in Nanopublications for { ?s ?p "DDI between Tamoxifen and Warfarin - Tamoxifen, a CYP2C9 inhibitor, may increase the serum concentration of warfarin by decreasing its metabolism. Concomitant therapy is contraindicated due to significant increase in bleed risk. [drugbank_resource:DB00675_DB00682]"@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- drugbank_resource:DB00675_DB00682 label "DDI between Tamoxifen and Warfarin - Tamoxifen, a CYP2C9 inhibitor, may increase the serum concentration of warfarin by decreasing its metabolism. Concomitant therapy is contraindicated due to significant increase in bleed risk. [drugbank_resource:DB00675_DB00682]" assertion.